abstract |
The present invention provides the use of a CNS-penetrant NK-1 receptor antagonist in an oral, once-a-day medicament for the treatment of major depressive disorder, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions comprising it. |